The epigenomics of cancer.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Cell

• Publication date

  2007-02-23

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/J.CELL.2007.01.029PMID 17320506PMCID PMC3894624
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identity

  2021cited by this paper
• EPIGENETIC REGULATION OF CELLULAR MEMORY BY THE POLYCOMB AND TRITHORAX GROUP PROTEINS

  2008cited by this paper
• Epigenetic stem cell signature in cancer

  2007cited by this paper
• Polycomb-mediated methylation on Lys27 of histone H3 pre-marks genes for de novo methylation in cancer

  2007cited by this paper
• WHAT IS THE ROLE OF INFLAMMATION IN THE PATHOGENESIS OF PROSTATE CANCER?

  2007cited by this paper
• The Polycomb group protein EZH2 directly controls DNA methylation

  2007cited by this paper
• Polycomb complexes repress developmental regulators in murine embryonic stem cells

  2006cited by this paper
• Molecular basis for site-specific read-out of histone H3K4me3 by the BPTF PHD finger of NURF

  2006cited by this paper
• Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions.

  2006cited by this paper
• The epigenetic progenitor origin of human cancer

  2006cited by this paper
• CpG island methylator phenotype underlies sporadic microsatellite instability and is tightly associated with BRAF mutation in colorectal cancer

  2006cited by this paper
• Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

  2006cited by this paper
• Anticancer activities of histone deacetylase inhibitors

  2006cited by this paper
• Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

  2006cited by this paper
• Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a

  2006cited by this paper
• A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling

  2006cited by this paper
• p16INK4a induces an age-dependent decline in islet regenerative potential

  2006cited by this paper
• The Polycomb group protein EZH2 directly controls DNA methylation

  2006cited by this paper
• Genome-wide hypomethylation in human glioblastomas associated with specific copy number alteration, methylenetetrahydrofolate reductase allele status, and increased proliferation.

  2006cited by this paper
• Increasing p16INK4a expression decreases forebrain progenitors and neurogenesis during ageing

  2006cited by this paper
• Epigenetic remodeling in colorectal cancer results in coordinate gene suppression across an entire chromosome band

  2006cited by this paper
• DNA methylation profiling of human chromosomes 6, 20 and 22

  2006cited by this paper
• Mouse Polycomb Proteins Bind Differentially to Methylated Histone H3 and RNA and Are Enriched in Facultative Heterochromatin

  2006cited by this paper
• The epigenetic magic of histone lysine methylation

  2006cited by this paper
• A bivalent chromatin structure marks key developmental genes in embryonic stem cells.

  2006cited by this paper
• Myc influences global chromatin structure

  2006cited by this paper
• Silenced tumor suppressor genes reactivated by DNA demethylation do not return to a fully euchromatic chromatin state.

  2006cited by this paper
• Specific activation of microRNA-127 with downregulation of the proto-oncogene BCL6 by chromatin-modifying drugs in human cancer cells.

  2006cited by this paper
• Inflammation, a Key Event in Cancer Development

  2006cited by this paper
• Control of developmental regulators by Polycomb in human embryonic stem cells.

  2006cited by this paper
• Inhibition of SIRT1 Reactivates Silenced Cancer Genes without Loss of Promoter DNA Hypermethylation

  2006cited by this paper
• p16INK4a Prevents Centrosome Dysfunction and Genomic Instability in Primary Cells

  2006cited by this paper
• HIC1 attenuates Wnt signaling by recruitment of TCF‐4 and β‐catenin to the nuclear bodies

  2006cited by this paper
• Tumor Suppressor p16INK4A Regulates Polycomb-mediated DNA Hypermethylation in Human Mammary Epithelial Cells*

  2006cited by this paper
• The origin of the cancer stem cell: current controversies and new insights

  2005cited by this paper
• Epigenetic silencing mechanisms in budding yeast and fruit fly: different paths, same destinations.

  2005cited by this paper
• Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases.

  2005cited by this paper
• Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells.

  2005cited by this paper
• Brahma links the SWI/SNF chromatin-remodeling complex with MeCP2-dependent transcriptional silencing

  2005influential reference
• Composition and histone substrates of polycomb repressive group complexes change during cellular differentiation.

  2005cited by this paper
• Global histone modification patterns predict risk of prostate cancer recurrence

  2005cited by this paper
• Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses.

  2005cited by this paper
• Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer

  2005cited by this paper
• Cancer: Crime and punishment

  2005cited by this paper
• Comparison of biological effects of non-nucleoside DNA methylation inhibitors versus 5-aza-2′-deoxycytidine

  2005cited by this paper
• Opinion: the origin of the cancer stem cell: current controversies and new insights.

  2005cited by this paper
• The role of inflammation in the pathogenesis of prostate cancer.

  2004cited by this paper
• The SWI/SNF complex — chromatin and cancer

  2004cited by this paper
• Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins.

  2004cited by this paper
• Preferential response of cancer cells to zebularine.

  2004cited by this paper
• The history of cancer epigenetics

  2004cited by this paper
• Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer

  2004cited by this paper
• Polycomb, epigenomes, and control of cell identity.

  2003influential reference
• GATA-4 and GATA-5 Transcription Factor Genes and Potential Downstream Antitumor Target Genes Are Epigenetically Silenced in Colorectal and Gastric Cancer

  2003cited by this paper
• EZH2 is downstream of the pRB‐E2F pathway, essential for proliferation and amplified in cancer

  2003cited by this paper
• Genetics supersedes epigenetics in colon cancer phenotype.

  2003cited by this paper
• Prospective identification of tumorigenic breast cancer cells

  2003cited by this paper
• Synthesis of Signals for De Novo DNA Methylation in Neurospora crassa

  2003cited by this paper
• Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines.

  2003cited by this paper
• Methyl-CpG Binding Domain Protein 2 Represses Transcription from Hypermethylated π-Class Glutathione S-Transferase Gene Promoters in Hepatocellular Carcinoma Cells*

  2002cited by this paper
• The fundamental role of epigenetic events in cancer

  2002cited by this paper
• Inflammation and cancer

  2002cited by this paper
• The polycomb group protein EZH2 is involved in progression of prostate cancer

  2002cited by this paper
• Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2'-deoxycytidine.

  2002cited by this paper
• Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma.

  2002cited by this paper
• Role for DNA methylation in the control of cell type–specific maspin expression

  2002cited by this paper
• Sir2p and Sas2p opposingly regulate acetylation of yeast histone H4 lysine16 and spreading of heterochromatin

  2002cited by this paper
• Comprehensive analysis of CpG islands in human chromosomes 21 and 22

  2002cited by this paper
• Chromosomal gradient of histone acetylation established by Sas2p and Sir2p functions as a shield against gene silencing

  2002cited by this paper
• Histone deacetylases and cancer: causes and therapies

  2001cited by this paper
• DNA methylation patterns in hereditary human cancers mimic sporadic tumorigenesis.

  2001cited by this paper
• Sir2 links chromatin silencing, metabolism, and aging.

  2000cited by this paper
• Analysis of adenomatous polyposis coli promoter hypermethylation in human cancer.

  2000cited by this paper
• CpG island methylator phenotype in colorectal cancer.

  1999cited by this paper
• Cancer-epigenetics comes of age

  1999cited by this paper
• Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

  1999cited by this paper
• Inhibition of DNA methyltransferase stimulates the expression of signal transducer and activator of transcription 1, 2, and 3 genes in colon tumor cells.

  1999cited by this paper
• Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation.

  1999cited by this paper
• Aberrant methylation of p16(INK4a) is an early event in lung cancer and a potential biomarker for early diagnosis.

  1998cited by this paper
• Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation

  1998cited by this paper
• Distinct Functions Are Implicated for the GATA-4, -5, and -6 Transcription Factors in the Regulation of Intestine Epithelial Cell Differentiation

  1998cited by this paper
• Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription

  1998cited by this paper
• Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex

  1998cited by this paper
• Both Rb/p16INK4a inactivation and telomerase activity are required to immortalize human epithelial cells

  1998cited by this paper
• Requirement of the transcription factor GATA4 for heart tube formation and ventral morphogenesis.

  1997cited by this paper
• Lessons from Hereditary Review Colorectal Cancer

  1996cited by this paper
• E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas.

  1995cited by this paper
• GATA-4/5/6, a subfamily of three transcription factors transcribed in developing heart and gut.

  1994cited by this paper
• Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity.

  1988cited by this paper
• On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs.

  1983cited by this paper
• 5-methylcytosine, gene regulation, and cancer.

  1983cited by this paper
• Cellular differentiation, cytidine analogs and DNA methylation.

  1980cited by this paper
• Functional striated muscle cells from non-myoblast precursors following 5-azacytidine treatment

  1977cited by this paper
• [Inflammation and cancer].

  1974cited by this paper
• Review Stem Cells and Cancer: The Polycomb Connection

  year unknowncited by this paper

• Synthesis, Nanoformulation, Molecular Modeling, and Anticancer Studies of 1,2,3-Triazole/Oxo-2-Thioxo-Thiazolidine Hybrids Using NF-κB and p-AMPK Pathways

  2026cites this paper
• The Epigenetic Angle in the Precision Medicine Era for Blood Disorder Advancements.

  2026cites this paper
• The transcribed ultraconserved regions: emerging players in colorectal cancer biology and therapy

  2026cites this paper
• Advances in photopharmacology: Fluorescent photoisomers for precision cancer theranostics

  2026cites this paper
• Capsaicin-Inspired Hydroxamate Hybrids as Selective HDAC6 Inhibitors with Antiproliferative Activity in Hematological Malignancies

  2026cites this paper
• Gene Methylation Profile in Hematologic Malignancies

  2026cites this paper
• AMDRP: adaptive drug feature fusion and multihead bidirectional cross-attention network for drug-cancer cell response prediction.

  2026cites this paper
• The Great Potential of DNA Methylation in Triple-Negative Breast Cancer: From Biological Basics to Clinical Application

  2026cites this paper
• Comprehensive epigenetic analysis on 5-methylcytosine modification of circRNAs in the mouse cerebral ischemia model.

  2026cites this paper
• Targeting BRD4—A Promising Therapeutic Option for Glioblastoma?

  2026cites this paper
• DNA Methylation and Its Role in Personalized Nutrition: Mechanisms, Clinical Insights, and Future Perspectives

  2026cites this paper
• Prokaryotic Molecular Defense Mechanisms and Their Potential Applications in Cancer Biology: A Special Consideration for Cyanobacterial Systems

  2026cites this paper
• Assessment of the carcinogenic potential of automotive gasoline in humans based on mechanistic evidence.

  2026cites this paper
• Genome-wide profiling of salivary promoter-region DNA methylation in periodontitis: the Tromsø study.

  2026cites this paper
• Advances in Colorectal Cancer Cell Biology and Clonal Evolution

  2026cites this paper
• Unveiling the epigenetic landscape of AMPK regulation in cancer metabolism.

  2026cites this paper
• Peripheral Blood Biomarkers in Non-Hodgkin Lymphoma: Evaluation of Classical Serological Markers and Emerging Liquid Biopsy Approaches

  2026cites this paper
• GPCR-Mediated Cell Intelligence: A Potential Mechanism for Survival and Long-Term Health.

  2026influential citation
• Mechanistic insights and emerging role of ripe papaya derived pectin as a natural polymer in cancer prevention and therapy

  2025cites this paper
• Gastric Cancer after Helicobacter pylori Eradication: Characteristics, Diagnosis, and Management.

  2025cites this paper
• Emerging involvement of CXCL13 in cancer development and progression.

  2025cites this paper
• Advances in Cancer Treatment Through Nanotheranostics and Emerging Therapies

  2025cites this paper
• Integrating Inflammatory and Epigenetic Signatures in IBD-Associated Colorectal Carcinogenesis: Models, Mechanisms, and Clinical Implications

  2025cites this paper
• The role of DNA methylation in directing treatment in medulloblastoma.

  2025cites this paper
• In Silico Identification of DNMT Inhibitors for the Treatment of Glioblastoma

  2025cites this paper
• Global DNA methylation signatures associated with chemoresistance and poor prognosis of high grade serous ovarian cancer

  2025cites this paper
• Mitochondrial-Based Nanomedicine in Treatment of Liver Cancer.

  2025cites this paper
• Integrated Multi-Omics Analysis Identifies Novel Prognostic and Diagnostic Hub Genes in Colorectal Cancer

  2025cites this paper
• Epigenetic drugs in cancer therapy: mechanisms, immune modulation, and therapeutic applications

  2025cites this paper
• HCCS Serves as Potential Prognostic Biomarker and Therapeutic Target in Human Breast Cancer

  2025cites this paper
• Epigenetic therapies in hepatocellular carcinoma: emerging clinical tools and applications

  2025cites this paper
• Dynamic analysis of a breast cancer model with SGLT2 inhibitor and vitamin combination therapy

  2025cites this paper
• Cancer Reversion Therapy: Prospects, Progress and Future Directions

  2025cites this paper
• ÖRGÜTSEL ÖĞRENMENİN, ÇALIŞANLARIN ÖZ YETERLİLİK VE İNOVASYON PERFORMANSINA ETKİLERİ

  2025cites this paper
• Methylation-sensitive high-resolution melting technology is a simple and sensitive method to detect germline epimutation of the MLH1 gene promoter

  2025cites this paper
• FAM111B as a biomarker influences the prognosis and immune microenvironment of low-grade gliomas.

  2025cites this paper
• Dihydrotestosterone-androgen receptor signaling suppresses EBV-positive gastric cancer through DNA demethylation-mediated viral reactivation

  2025cites this paper
• The Possibility of DNA Methylation for Precision Medicine in Colorectal Cancer

  2025cites this paper
• Cancer‐Type‐Specific DNA Methylation Is a Source of Vulnerability in Liver Cancer Cells

  2025cites this paper
• Endocrine-disrupting chemicals as prostate carcinogens

  2025cites this paper
• Phytochemicals Alleviate Tumorigenesis by Regulation of M1/M2 Polarization: A Systematic Review of the Current Evidence

  2025cites this paper
• Evaluation of the Impact of the COVID-19 Pandemic on the Incidence of Cancer: A Comparative Analysis between the Years 2018 and 2022

  2025cites this paper
• Case Report: Successful late-line pralsetinib treatment in an ALK-rearranged lung adenocarcinoma patient with KIF5B-RET fusion resistant to alectinib

  2025cites this paper
• Single‐component cationic polyethylenimine thermogel for sustained and localized gene delivery to combat multi‐drug resistant cancer

  2025cites this paper
• Direct genetic transformation bypasses tumor-associated DNA methylation alterations

  2025cites this paper
• Transcriptome-wide association study of prostate cancer in Chinese population

  2025cites this paper
• Research Progress on Epigenetic Regulation in Neurodegenerative Diseases

  2025cites this paper
• Deep Raman Quantitative Profiling and Augmented Features for Biologically Interpretable GI Cancer Detection.

  2025cites this paper
• Pan-cancer multi-omics profiling reveals ubiquitin D as a novel biomarker for diagnosis, immune microenvironment remodeling and prognostic prediction

  2025cites this paper
• Genome-wide profiling of unmodified DNA using methyltransferase-directed tagging and enrichment

  2025cites this paper
• SPAG6 hypermethylation silences a novel tumor suppressor and inhibits renal cell carcinoma progression via PI3K/AKT/mTOR pathway

  2025cites this paper
• Cross-Platform DNA Methylation Classifier for the Eight Molecular Subtypes of Group 3 & 4 Medulloblastoma

  2025cites this paper
• Epigenetic regulation of Cereblon in cancer: molecular mechanisms and clinical implications

  2025cites this paper
• Proximity effects and disease-related differences in DNA methylation among asthma patients near the Sohar Industrial Port, Oman.

  2025cites this paper
• Emerging hallmarks and the rise of complexities and heterogeneity of tumor

  2025cites this paper
• An attempt to personalize approaches to the treatment of patients with amyotrophic lateral sclerosis: analysis of immunological parameters of bone marrow cells and clonal hematopoiesis

  2025cites this paper
• Epigenetics in Ovarian Cancer: A Review of Current Knowledge and Future Perspectives

  2025cites this paper
• Systems Theory in Oncology: A Narrative Review of an Integrative Framework for Understanding Cancer Complexity

  2025cites this paper
• Use of DNA methylation patterns for early detection and management of lung cancer: Are we there yet?

  2025cites this paper
• Fabrication of Cu(II)-porphyrin complex-conjugated chitosan nanoparticles for catalytic, oxidation, and biomedical applications.

  2025cites this paper
• Epigenetic regulation of the tumor microenvironment in lung cancer: mechanism insights and therapeutic prospects

  2025cites this paper
• In vitro and in silico insights into moniliformin induced global DNA methylation in liver cells

  2025cites this paper
• Epigenetic Regulation of PEPT2 as a Novel Strategy to Improve the Antitumor Efficacy of Lenalidomide in Clear Cell Renal Cell Carcinoma

  2025cites this paper
• Targeting epigenetic effects of androgen-androgen receptor signaling in prostate cancer.

  2025cites this paper
• DeepMethyGene: a deep-learning model to predict gene expression using DNA methylations

  2025cites this paper
• Kaempferol Targets Global Epigenetic Modifiers to Impedes Growth and Migratory Ability of HeLa Cells

  2025cites this paper
• Charged multivesicular body protein 4C promotes the progression of cervical cancer through the HPV E6/miR‑543 axis

  2025cites this paper
• DNA methylation signatures of cervical pre‐invasive and invasive disease: An epigenome‐wide association study

  2025cites this paper
• A comprehensive prognostic and immune analysis of LAPTM4B in pan-cancer and Philadelphia chromosome-positive acute lymphoblastic leukemia

  2025cites this paper
• DNA methylation alterations in prostate cancer: from diagnosis to treatment

  2025cites this paper
• Unlocking the Mysteries of Breast Cancer

  2025cites this paper
• Unravelling the epigenetic based mechanism in discovery of anticancer phytomedicine: Evidence based studies.

  2025cites this paper
• Zinc finger protein ZC3H18 is abnormally expressed in esophageal cancer tissues and facilitates the proliferation of esophageal cancer cells

  2025cites this paper
• Current advances and future directions in targeting histone demethylases for cancer therapy

  2025cites this paper
• Unveiling the power of glycyrrhizic acid-loaded chitosan nanoparticles: an in-depth exploration of their pharmacological mechanism in combatting colorectal cancer

  2025cites this paper
• Mathematical models for self-adaptive response to cancer dynamics

  2025cites this paper
• Epigenetics and cancer stem cells-The world of cancer genesis: A review.

  2025cites this paper
• Cancer-drug response prediction via feature aggregation and association graph learning

  2025cites this paper
• In Vivo Reprogramming Highlights Epigenetic Regulation That Shapes Cancer Hallmarks

  2025cites this paper
• Evaluation of Illumina and Oxford Nanopore Sequencing for the Study of DNA Methylation in Alzheimer’s Disease and Frontotemporal Dementia

  2025cites this paper
• Carcinogenicity of food additives: A review

  2025cites this paper
• The emerging role of epigenetics (DNA methylation) in hepatitis C virus-induced hepatocellular carcinoma

  2025cites this paper
• Simulated Microgravity-Induced Alterations in PDAC Cells: A Potential Role for Trichostatin A in Restoring Cellular Phenotype

  2025cites this paper
• Multiomics analysis of umbilical cord hematopoietic stem cells from a multiethnic cohort of Hawaii reveals the intergenerational effect of maternal prepregnancy obesity and risks for cancers

  2025cites this paper
• Epigenetic modifications in follicular cell-derived thyroid cancer: new dimensions in pathogenesis and treatment

  2025cites this paper
• Altered gene expression pattern due to different tumor percentage affects functions

  2025cites this paper
• Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer.

  2025cites this paper
• The role of pioneering transcription factors, chromatin accessibility and epigenetic reprogramming in oncogenic viruses

  2025cites this paper
• Detection of Cisplatin Resistance in Bladder Cancer Using Machine Learning

  2025cites this paper
• Fumonisin B1 induces global DNA hypermethylation in human glioblastoma U87MG cells

  2025cites this paper
• Machine learning for genomic profiling and drug discovery in personalised lung cancer therapeutics

  2025cites this paper
• The dark matter in cancer immunology: beyond the visible– unveiling multiomics pathways to breakthrough therapies

  2025cites this paper
• Novel cancer subtyping method guided by tumor-normal sample in latent space of transcriptomic variational autoencoder

  2025cites this paper
• Epigenetic Modulation and Brain Function in Parkinson's Disease: The Role of Exercise Alone or Combined With Polyphenols

  2025cites this paper
• Discovery of Potential Selective HDAC8 Binders: Using Combination of Pharmacophore‐Based–Structure‐Based Virtual Screening, ADME Filtration, and Molecular Dynamics Studies

  2025cites this paper
• Inflammatory mitochondrial signalling and viral mimicry in cancer

  2025cites this paper
• Colorectal cancer chemoprevention: Exploring the path from molecular mechanisms to available drugs.

  2025cites this paper
• Novel role of MKRN2 in regulating tumor growth through host microenvironment and macrophage M1 to M2 switch.

  2025cites this paper
• Targeted and epigenetic therapies for acute myeloid leukemia treatment

  2025cites this paper
• Design, Development, And In Vitro Evaluation of Etoposide- Loaded Lipid Nanocarriers for Enhanced Bio accessibility and Sustained Drug Release for Targeted Therapy in Small Cell Lung and Testicular Cancer

  2025cites this paper